-
Mashup Score: 0
A phase 2, open-label clinical trial is evaluating treatment with QBS72S in patients with histologically-confirmed breast cancer that has developed brain metastases after a prior cytotoxic chemotherapy regimen.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
With all patients with solid tumors enrolled in the phase 1 study of QBS72S, 2 more studies evaluating the agent in brain malignancies will commence.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
With all patients with solid tumors enrolled in the phase 1 study of QBS72S, 2 more studies evaluating the agent in brain malignancies will commence.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
The first patient has been dosed with #QBS72S in a phase 2 trial evaluating the agent for the treatment of brain metastases of breast cancers. #bcsm https://t.co/WLV7f90S4i